KR930700094A - Obstructive Pulmonary Disease Therapeutics - Google Patents

Obstructive Pulmonary Disease Therapeutics

Info

Publication number
KR930700094A
KR930700094A KR1019920702486A KR920702486A KR930700094A KR 930700094 A KR930700094 A KR 930700094A KR 1019920702486 A KR1019920702486 A KR 1019920702486A KR 920702486 A KR920702486 A KR 920702486A KR 930700094 A KR930700094 A KR 930700094A
Authority
KR
South Korea
Prior art keywords
pulmonary disease
obstructive pulmonary
disease therapeutics
therapeutics
imidazolylmethyl
Prior art date
Application number
KR1019920702486A
Other languages
Korean (ko)
Inventor
사토시 기타무라
준 고바야시
기로 나카하라
Original Assignee
스즈키 다다시
다이이치세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스즈키 다다시, 다이이치세이야쿠 가부시키가이샤 filed Critical 스즈키 다다시
Publication of KR930700094A publication Critical patent/KR930700094A/en

Links

Abstract

내용 없음.No content.

Description

폐쇄성 폐질환 치료제Obstructive Pulmonary Disease Therapeutics

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (1)

6-(1-이미다졸릴메틸)-5,6,7,8-테트라하이드로나프탈렌-2-카복실산 또는 이의 약제학적으로 허용되는 염을 유효성분으로서 포함하는 폐쇄성 폐질환에 대한 예방 및 치료제.A prophylactic and therapeutic agent for obstructive pulmonary disease comprising 6- (1-imidazolylmethyl) -5,6,7,8-tetrahydronaphthalene-2-carboxylic acid or a pharmaceutically acceptable salt thereof as an active ingredient. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019920702486A 1990-04-09 1991-04-09 Obstructive Pulmonary Disease Therapeutics KR930700094A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP90-93584 1990-04-09

Publications (1)

Publication Number Publication Date
KR930700094A true KR930700094A (en) 1993-03-13

Family

ID=

Similar Documents

Publication Publication Date Title
KR920019342A (en) Bone Disease Treatment
MX9300014A (en) NEW DERIVATIVES OF 1,2,4-TRIAMINOBENZENE AND PROCESS FOR ITS PREPARATION.
LU90234I2 (en) A combination comprising lamivudine optionally in the form of a pharmaceutically acceptable salt and zidovudine
KR890015742A (en) Topical preparations for the treatment of diseases
NO910935D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE C-BONDED PYRAZOLE DERIVATIVES.
KR910000703A (en) Antagonists of Tetrazol Stimulating Amino Acid Receptors
KR940018087A (en) 6-chloro-5-fluoro-3- (2-tenoyl) -2-oxindol-I-carboxamide as analgesic and anti-inflammatory agent
KR910000158A (en) Medicinal Compounds and How to Use Them
FR2656214B1 (en) DYNAMIC FRAMEWORK OF RACHIS OSTEOSYNTHESIS.
ATE66133T1 (en) CONDOM.
ITMI931973A0 (en) DERIVATIVES OF 2-AMINO-1,2,3,4-TETRAUDRO-NAPHTHALENE ACTIVE ON THE CARDIOVASCULAR SYSTEM
DE69213183D1 (en) N'-cyanomethylethylenediamine-N, N'-diacetic acid, their salts and their preparation
EP0291269A3 (en) Anti-tumour sulfonyl urea derivatives
FI910112A (en) PREPARAT FOER LOKALT BRUK.
KR930700094A (en) Obstructive Pulmonary Disease Therapeutics
KR980000445A (en) Recognition enhancer method
MX9205385A (en) PERHYDRO-1-H-PIRIDO (1,2-A) PIRACINAS 2-SUBSTITUTED NEUROLEPTICAS.
IE893578L (en) Phenyloxypropanolamine derivatives, their preparation and¹their application in therapeutics
WO2000002877A3 (en) New pharmaceutically active compounds
NO913644D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AMINO ACID DERIVATIVES.
KR960003718A (en) Use of Ifenprodil and its Diastereomers for the Preparation of Medicines Useful for the Treatment of Peripheral and Central Neurodegenerative Diseases
KR910000645A (en) Improved Spasm Treatment
KR100194995B1 (en) Agents for the treatment of coronary heart disease, atherosclerosis and / or lipoprotein metabolic disorders
KR960021045A (en) Hepatitis B Therapeutics Containing Ferric Acid
IT1216556B (en) PEPTIDAL DERIVATIVES OF 3_AMINODIIDROTIOFEN_2_ONE, THEIR PREPARATION AND THERAPEUTIC USE.